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Skin cancer is common among white populations and ra-
pid increases in incidence are being observed in many 
countries, leading to a large burden on healthcare sys-
tems. Unnecessary referrals from general practitioners 
(GPs) may contribute to this burden. The aim of this 
study was to analyse the quality of referrals from GPs 
of patients with skin tumours. Referral letters for 734 
patients were collected. The proposed diagnoses were 
compared with definitive diagnosis made by dermatolo-
gists. In 44.5%, lesions appeared to be benign. Malignant 
skin tumours were poorly recognised by GPs and seborr-
heic keratoses were often mistaken for naevi (33.6%). 
Furthermore, with total body examination, dermatolo-
gists found 111 additional malignant lesions. We discu-
ssed several recommendations to minimise unnecessary 
referrals as well as the future role of GPs in skin cancer 
care. Key words: skin cancer; general practitioner; educa-
tion; total body examination; unnecessary referrals.
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Skin cancer (SC) is a public health problem of increasing 
magnitude among fair-skinned populations worldwide, 
and it is responsible for an increasing contribution to 
health care costs (1, 2). The occurrence of SC at young 
age (3, 4) and the development of multiple tumours in 
many SC patients contributes to this problem (5). A 
recent study showed that almost one in 5 persons will 
develop SC (6). 
Basal cell carcinoma (BCC), squamous cell car-
cinoma (SCC), and the premalignancies SCC in situ 
(SCC i.s.) and actinic keratosis (AK) belong to the 
group of non-melanoma skin cancers (NMSC). In these 
skin malignancies, the mortality rate is low; however, 
morbidity and disfigurement may be caused by excision 
of large tumours in functional and visible areas. The 
incidence of melanoma is much lower (4, 7), but these 
tumours are responsible for the highest mortality rate. 
Treatment of SCC i.s. and high risk AKs, especially in 
those with multiple lesions (e.g. field cancerisation), 
is recommended to eliminate the risk of evolution into 
invasive SCC (8). Early detection may lower SC as-
sociated morbidity and mortality.
 Most skin cancer presents in primary care, and an 
important determinant of outcome may be initial recog-
nition and management of the lesion. Previous studies 
have shown that general practitioners (GPs) have dif-
ficulties in diagnosing various types of skin diseases, 
including SC (9–11). A study performed in the U.K. 
showed that 81% of malignancies sent for pathological 
analysis, was treated by dermatologists and 2% by GPs, 
the others were treated by other hospital physicians (12). 
The latter may indicate that GPs refer high numbers of 
patients to dermatologists. The aim of our study was to 
investigate the necessity and quality of referrals made 
by GPs in a population of patients with skin tumours.
METHODS
Study population
We collected all referral letters sent by GPs of patients who were 
referred with the diagnosis of a possible skin tumour to the de-
partment of Dermatology of the Radboud University Nijmegen 
Medical Centre (RUNMC) in the period from January 2008 to 
November 2010. Selection was based on the final diagnosis of a 
malignant or benign tumour in the hospital’s registration system. 
This computerised system is able to perform a patient selection 
based on a patient’s final diagnosis. Only few patients who were 
incorrectly diagnosed may be missed in our inclusion. Of all 
patients, referral letters, dermatological charts (filled out by the 
dermatologist or dermatology resident [DR]), and pathological 
results (when available) were collected. 
The following data were recorded: 1) socio-demographic 
data including gender and age; 2) description of the lesion; 3) 
the number of diagnostic biopsies; 4) the referral diagnosis; 5) 
listed number; and 6) location of (additional) lesions found by 
dermatologist or DR. 
The diagnoses at referral were compared with the pathological 
diagnoses. If no additional pathological analysis was performed, 
the clinical diagnosis made by the dermatologist or DR was 
used as the final diagnosis. If necessary, mainly in case of a 
pigmented lesion or BCC, dermatologists or DRs made use of 
a dermatoscope. Since the RUNMC is a training hospital, many 
clinical diagnoses of DRs were confirmed by a supervising 
dermatologist. In case a differential diagnosis was proposed, 
the first diagnosis mentioned was used in the analysis. 
A diagnosis was defined as ‘correct’ when the diagnosis of 
the GP was in line with the diagnosis of the dermatologist and 
DR, or (if available) with the pathologic results. The differential 
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diagnoses of the dermatologists and DRs were defined as ‘cor-
rect’ when they were in line with the pathological diagnosis. 
Therefore, the dermatologists’ and DRs’ diagnoses could only 
be verified in case a pathological result was available; mainly 
in malignancies and some premalignancies. 
Data analysis
Statistic analysis was performed using the Statistical Package 
for Social Sciences (SPSS®) for Windows (version 20.0). Only 
descriptive statistics were used. 
RESULTS
A total of 734 referral letters were collected from pa-
tients referred by GPs to the department of Dermato-
logy at the RUNMC. The population consisted of 325 
men (44.3%) and 409 women (55.7%), with a mean 
age of 58.3 years.
Location and number of lesions
Over 90% of patients were referred by their GP with 
one suspicious lesion. In < 10% the GP discovered > 1 
lesion. Of all lesions, 61.0% was located on the face 
or scalp, 29.3% on the trunk or extremities and 5.9% 
on multiple body parts. In 3.8% the lesion location was 
not mentioned in the referral letter.
By performing total body examination, dermatolo-
gists and DRs diagnosed 234 additional premalignant 
and malignant lesions, including AKs, SCC i.s., dys-
plastic naevi, BCCs, SCCs, melanomas, and atypical 
fibroxanthoma (Table I). 
Diagnostics
Overall, 327 (44.5%) of the lesions, which were reason 
for referral appeared to be benign, 204 (27.8%) were 
malignant, and 204 (27.8%) premalignant. Of the 255 
lesions referred as malignant, 22.4% was diagnosed 
as premalignant and 25.1% as benign. Of all lesions 
referred as benign, 63.9% was diagnosed as benign. A 
cross tabulation of GPs’ diagnosis at referral and the 
final diagnosis presents an overview of the most oc-
curring diagnostic errors made in these referrals (Table 
II). Additionally, positive predictive values (PPV) for 
GPs’ diagnosis at referral were calculated (Table III). 
In 18.3% of the referrals a diagnosis was missing, 
the correct diagnosis was mentioned in 39.8% of let-
ters. In 1.2% a diagnostic biopsy was taken by the GP 
prior to referral.
Non-melanoma skin cancer
GPs referred 188 patients with the possible diagnosis 
of a BCC. Ninety-one of these were finally diagnosed 
with a BCC, 11 with SCC, 34 with AK, one with SCC 
i.s., one melanoma, and 45 with benign lesions. Of 153 
patients who were ultimately diagnosed with BCC, 
29 were referred without a diagnosis, and 16 with the 
question ‘malignant’. Out of 38 SCCs, 6 were referred 
as SCC. None of the 13 SCC i.s. was referred with this 
diagnosis. 
As compared to the pathological diagnosis, derma-
tologists and DRs mentioned the correct diagnosis of 
a BCC in 95.4%, a SCC in 55.3%, and a SCC i.s. in 
30.8%. Additional PPVs were calculated (Table III). 
Table I. Additional lesions found by dermatology resident or 
dermatologist after referral by general practitioner. Total of 146 
patients with additional lesions (min. 1 and max. 20 per patient)
Head/
neck Limbs Trunk
Total 
lesions
Premalignancies
Actinic keratosis 75 14 15 104
Dysplastic naevus 0 0 5 5
Squamous cell carcinoma in situ 9 3 2 14
Total 123
Malignancies
Basal cell carcinoma 36 12 48 96
Squamous cell carcinoma 6 0 2 8
Melanoma 1 0 4 5
Atypical fibroxanthoma 2 0 0 2
Total 111
Table II. Overview of referral diagnosis of general practitioner (GP) and the final diagnosis. 
Diagnosis made by GP
Final diagnosis
TotalBCC SCC AK
SCC 
i.s. Melanoma Other benign
Other 
malignant  SK
Naevus/
lentigo
Dysplastic 
naevus
Basal cell carcinoma (BCC) 91 11 34 6 1 26 0 11 8 0 188
Squamous cell carcinoma (SCC) 3 6 4 1 0 5 0 0 0 0 19
Actinic keratosis (AK) 7 4 72 1 0 8 0 4 2 0 98
SCC in situ (SCC i.s.) 0 1 0 0 0 0 0 0 0 0 1
Melanoma 0 0 0 0 2 0 0 0 1 0 3
Other benign 4 5 14 1 1 34 2 6 5 0 72
Other malignant/’Malignant?’ 16 2 12 0 0 2 1 10 1 0 44
Seborrheic keratosis (SK) 1 1 0 0 1 3 0 32 1 0 39
Naevus/lentigo 2 0 3 0 1 5 0 33 62 1 107
Diagnosis missing 29 8 48 4 0 16 1 20 8 0 134
Dysplastic naevus 0 0 3 0 2 1 0 9 14 0 29
Total 153 38 190 13 8 100 4 125 102 1 734
Bold figures represents number of correct diagnosis by GPs.
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Pigmented lesions
Forty-two of 125 of the finally diagnosed seborrheic ke-
ratosis were referred as (atypical) naevi. Furthermore, in 
2 out of 8 melanomas and of 62 out of 102 benign naevi 
the correct diagnosis was mentioned in the referral letter. 
As compared to the pathological diagnosis, derma-
tologists and DRs mentioned the correct diagnosis of a 
melanoma in 62.5% and a dysplastic naevus in 100%. 
Additional PPVs were calculated (Table III). 
Lesion description 
In 15.4% of the referrals, GPs added an adequate le-
sion description by using dermatological terminology. 
In 24.0%, a lesion description was missing, in 39.5% 
the word ‘spot’ was used as a description, in 5.3% the 
word ‘lesion’, and in 15.8% the description: ‘looks 
like’ was used. 
DISCUSSION
The present study provides insight in the quality of 
GPs’ referrals of patients with skin tumours, and their 
ability to differentiate between malignant and benign 
skin lesions. 
Forty-four percent of all referred patients had benign 
tumours. Therefore, the question arises whether these 
referrals were really necessary, and if these numbers 
might be reduced in the future. 
With respect to NMSC, we found that GPs made the 
diagnosis of BCC in 188 of 734 referrals (PPV 48.4%); 
45 of these lesions were diagnosed as benign. The fact 
that the referral diagnosis of BCC was commonly used 
for other tumours may be explained by the fact that 
BCCs are more common than other malignancies (4, 7, 
13) and therefore BCC might be the first diagnosis a GP 
thinks of in these cases. Furthermore, it was also found 
that dermatologists and DRs were also less accurate in 
the diagnosis of SCC and SCC i.s., meaning that these 
tumours are probably more difficult to recognise (14). 
Almost 1/3 of SCCs was referred with the diagnosis 
of BCC. Given the fact that BCCs do not metastasise, 
whereas SCCs have the potential to do so, this may 
have the effect that patients with a SCC are not seen by 
a dermatologist with the urgency needed. In this study, 
only a few GPs provided an adequate lesion descrip-
tion (15.4%) or performed a biopsy (1.2%). In case of a 
misdiagnosis (e.g. SCC referred as BCC), an adequate 
lesion description may help the dermatologist to triage 
the correct level of priority for a hospital appointment. 
The encouragement of biopsy use in primary care may 
be worthwhile since it may lower the number of unne-
cessary referrals and contribute to the decision of the 
urgency of a referral. Furthermore, the performance 
of a biopsy may provide immediate reflection on their 
differential diagnosis, which could be of educational 
value. On the other hand, in case of a suspicious lesion, 
a dermatologist might perform an excision without 
previous biopsy, in which case referral without biopsy 
would save pathological costs. 
In pigmented lesions GPs only recognised 25.6% of 
seborrheic keratosis (SK), although they are very com-
mon. Thirty-four percent of these SK were diagnosed 
as (atypical) naevi, a misdiagnosis which is often made 
(15, 16). Furthermore, only 2 out of 8 melanomas and 
62 out of 102 benign naevi were correctly diagnosed. 
This might indicate that GPs have difficulty in diffe-
rentiating between pigmented lesions. There are some 
studies which indicate that dermatoscopy would be of 
additional value for GPs (17, 18). This may suggest 
that dermatoscopy may help GPs in differentiating SK 
from other pigmented lesions, which might reduce un-
necessary referrals. However, appropriate training and 
frequent use are necessary for adequate dermatoscopy 
performance and the question may arise whether GPs 
would make sufficient use of dermatoscopy to gain its 
additional value.
The number of additional lesions found in these 
patients is alarming, and proves the fact that many SC 
patients develop more than one lesion. The distribution 
of SC over the body surface has been described in se-
veral studies, showing that SC not only appears on the 
chronically sun-exposed areas of the skin (4, 19, 20), 
which pleads for total body examination. In a study 
of Terril et al. (21), additional (treatment requiring) 
skin lesions were detected in 67% out of 100 referred 
patients, 34 of the additional lesions were localised on 
sites covered by clothing. Therefore, we conclude that 
total body examination is not performed on a large 
scale, although it would lead to early SC detection. An 
explanation of the fact that GPs do not perform full body 
examination in all cases, could be unawareness of the 
lesion distribution over the body surface or lack of time. 
A possible limitation of our study may be that, in case 
of a differential diagnosis, only the diagnosis listed first 
was included in our analysis. Therefore, in some cases 
the GP or dermatologist and DR could have mentioned 
the correct diagnosis, but not first in line. Additionally, 
Table III. Positive predictive values of general practitioners’ (GPs) 
diagnosis mentioned in the referral letter and of dermatologists and 
dermatology residents (DR) prior to pathological results
Diagnosis 
Positive predictive values
GP, % Dermatologist and DR, %
Basal cell carcinoma 48.4 72.6
Squamous cell carcinoma 31.6 65.6
Actinic keratosis 73.5 Not applicable
Squamous cell carcinoma i.s. 0.0 28.6
Melanoma 66.7 100.0
Seborrheic keratosis 82.1 Not applicable
Naevus/lentigo 57.9 Not applicable
Dysplastic naevus 0.0 20.0
i.s.: in situ.
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it should be noted that GPs do not always have a di-
agnosis for a skin lesion, and sometimes only refer 
suspicious lesions with the question ‘malignant?’, or 
without a question or diagnosis, therefore, ‘malignant?’ 
and ‘diagnosis missing’ were also added to our cross 
tabulation. We also included benign tumours to establish 
a complete overview of (unnecessary) referrals made in 
the full array of skin tumours.
On the basis of our study, we conclude that refer-
rals of patients with skin tumours could be optimised. 
With the increasing incidence of SC it is worthwhile 
to reduce the number of unnecessary referrals, to gain 
more capacity for patients in need of specialist care, e.g. 
reducing the number of referrals of benign lesions may 
lead to a decrease of almost 50% of patients referred 
with skin tumours. 
Therefore, adequate training in clinical tumour charac-
teristics of most common SCs, and more frequent use of 
additional diagnostic techniques are worthwhile to gain 
appropriate competency in GPs. With the rising numbers 
of SC the question arises whether more specialised SC 
care performed by dermatologists is needed in primary 
care. Another solution might be the training of GPs with 
a special focus on dermatology to contribute to low-key 
dermatological care. In Australia this concept is already 
in use, as SC is a major health problem in the fair-skin 
population of this country, thereby leaving more capacity 
for dermatologists to treat severely affected patients. 
At present, GPs could contribute to optimise their 
referrals by adding appropriate dermatological lesion 
descriptions in their referral letters and by total body 
examination in patients with suspicious lesions. 
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